# Enumeral Biomedical Corp.: Form D filings

Enumeral Biomedical Corp., a biotechnology company in New York, NY, filed 5 Form D notices with the SEC between 2011 and 2014. The latest, on May 7, 2014, reports $2 million sold of an offering with no set size to 5 investors.

Find out what Enumeral Biomedical Corp. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Enumeral%20Biomedical%20Corp.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Enumeral%20Biomedical%20Corp.&page=%2Fdata%2Fform-d%2Fcompany%2Fenumeral-biomedical-corp-1518957)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Enumeral%20Biomedical%20Corp.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Enumeral%20Biomedical%20Corp.&page=%2Fdata%2Fform-d%2Fcompany%2Fenumeral-biomedical-corp-1518957)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1450 BROADWAY, 24TH FLOOR, New York, NY, 10018
- Phone: (347) 277-4787
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2009
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1518957

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 7, 2014 | New notice | Indefinite | $2,016,250 | Indefinite | 5 | Apr 25, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1518957/000151895714000003/0001518957-14-000003-index.htm) |
| Feb 10, 2014 | New notice | $750,000 | $635,000 | $115,000 | 6 | Feb 3, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1518957/000151895714000002/0001518957-14-000002-index.htm) |
| May 14, 2013 | New notice | Indefinite | $1,520,004 | Indefinite | 10 | Apr 30, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1518957/000090866213000216/0000908662-13-000216-index.htm) |
| Jul 9, 2012 | New notice | $3,000,000 | $2,272,973 | $727,027 | 17 | Jun 27, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1518957/000090866212000171/0000908662-12-000171-index.htm) |
| Apr 29, 2011 | New notice | $3,339,640 | $1,997,477 | $1,342,163 | 10 | Apr 19, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1518957/000090866211000101/0000908662-11-000101-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Emanuele H. Ostuni | Director |  |
| Michael H. Weiss | Director |  |
| Arthur H. Tinkelenberg | Executive Officer, Director |  |
| Allan H. Rothstein | Director |  |
| Barry H. Buckland | Director |  |
| Derek H. Brand | Executive Officer |  |
| John H. Rydzewski | Executive Officer, Director |  |
| Daniel H. Wolfe | Director |  |

## Other biotechnology companies in New York that filed recently

- [Swep Bio, Inc.](https://specstream.ai/data/form-d/company/swep-bio-inc-2159106) $2.5 million · Oct 29, 2026
- [Hypercell Technologies Inc.](https://specstream.ai/data/form-d/company/hypercell-technologies-inc-1882357) $3 million · Oct 14, 2026
- [CAD Therapeutics, Inc.](https://specstream.ai/data/form-d/company/cad-therapeutics-inc-2157566) $4 million · Oct 2, 2026
- [Vicora, Inc.](https://specstream.ai/data/form-d/company/vicora-inc-2091847) $2.3 million · Sep 18, 2026
- [GevRx Nutraceuticals, Inc.](https://specstream.ai/data/form-d/company/gevrx-nutraceuticals-inc-2156105) $300,000 · Sep 18, 2026
- [Episteme Prognostics, Inc.](https://specstream.ai/data/form-d/company/episteme-prognostics-inc-1902402) $5.1 million · Sep 4, 2026

[Every Form D from the week of May 5, 2014](https://specstream.ai/data/form-d/week/2014-05-05) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Enumeral Biomedical Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).